What did we learn from the North American Cystic Fibrosis Conference?
- PMID: 18607012
- PMCID: PMC2443991
- DOI: 10.1258/jrsm.2008.s18003
What did we learn from the North American Cystic Fibrosis Conference?
Figures
References
-
- CF Foundation. http://cf.org.
-
- Nissimi-Rafinia M, Kerem B, Kerem E. Molecular biology of cystic fibrosis: CFTR processing and functions, and classes of mutations. In: Hodson M, Geddes D, Bush A, editors. Cystic Fibrosis. 3rd edition. London: Hodder Arnold; 2007.
-
- Hirawat S, Welch EM, Elfring GL, et al. Safety, tolerability and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single and multiple-dose administration to healthy male and female adult volunteers. J Clin Pharmacol. 2007;47:430–44. - PubMed
-
- VanGoor F, Hadida S, Grootenhuis P. A potent selective and orally bioavailable potentiator of CFTR gating. Paed Pulmonol. 2007;S30:289.
-
- Grasemann H, Stehling F, Bruner H, et al. Inhalation of MOLI1901 in patients with cystic fibrosis. Chest. 2007;131:1461–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
